Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Cogstate Ltd ( (AU:CGS) ).
Cogstate Ltd has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program for its ordinary fully paid shares. The company reported that a total of 743,004 shares had been repurchased before the previous trading day, with an additional 1,795 shares bought back on the previous day.
This latest daily update, dated 19 March 2026, follows the company’s initial buy-back notification in November 2025 and shows that the program is continuing as scheduled. The ongoing purchases signal management’s commitment to capital management and may support the share price by reducing the number of shares on issue over time, which can be beneficial for existing shareholders.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd is an Australian-listed company trading under the ASX code CGS, with ordinary fully paid shares on issue. The firm operates in the cognitive science and technology space, providing tools and services that are typically used in clinical trials, healthcare, and research settings to assess cognitive function.
Average Trading Volume: 204,578
Technical Sentiment Signal: Buy
Current Market Cap: A$368.8M
See more data about CGS stock on TipRanks’ Stock Analysis page.